PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\', \'Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\', \'Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bph.15164
?:doi
?:hasPublicationType
?:journal
  • British journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32557557
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.603
?:rankingScore_hIndex
  • 186
is ?:relation_isRelatedTo_publication of
?:title
  • Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all